Leftover tumor tissue used to grow Mini-Tumors in lab
NCT ID NCT05786144
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study took leftover tumor tissue from 100 patients undergoing surgery for vestibular schwannoma (a non-cancerous brain tumor) and used it to grow stem cell organoids—tiny 3D versions of the tumor—in the lab. The goal was to create a living biobank to study why these tumors resist treatment. No new treatments were tested; the focus was on understanding the tumor's biology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR SCHWANNOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht University Medical Center
Maastricht, Limburg, 6229HX, Netherlands
-
Maastro
Maastricht, Limburg, 6229ET, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a precise radiation beam spare balance? a study investigates
- Smart sensors could predict falls in older adults with dizziness
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- Drug combo aims to shrink NF2 tumors and save hearing
- New hope for acoustic neuroma: direct brain infusion of avastin in early trial